Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Management of atherogenic hyperlipidemia]

G Turpin1, E Bruckert

  • 1Service d'Endocrinologie, Métabolisme Groupe Hospitalier Pitié-Salpêtrière, boulevard de l'Hôpital, Paris.

Annales De Cardiologie Et D'Angeiologie
|December 29, 1998
PubMed
Summary

Treatment for hyperlipoproteinaemia (high cholesterol/triglycerides) requires accurate diagnosis and tailored therapy. Prescribing lipid-lowering drugs, like statins or fibrates, depends on specific hyperlipidaemia types (IIa, IIb, IV) for optimal cardiovascular prevention.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Hypercholesterolemia, from screening to treatment: Who, why and how to manage].

La Revue de medecine interne·2020
Same author

Psychological predictors of the combined adoption of physical exercise and dietary change among adults with hypercholesterolemia.

Revue d'epidemiologie et de sante publique·2018
Same author

Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

[Statin treatment must be personalized].

La Revue de medecine interne·2018
Same author

[Familial hypercholesterolemia: A largely underestimated cardiovascular risk].

Annales de cardiologie et d'angeiologie·2017
Same author

Consensus statement on the management of dyslipidaemias in adults.

Annales d'endocrinologie·2017

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Pharmacology